Gontrand Lopez-Nava
Overview
Explore the profile of Gontrand Lopez-Nava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Francisco C, Ravi R, Lopez-Nava G, Asokkumar R
VideoGIE
. 2024 Oct;
9(10):460-462.
PMID: 39473555
No abstract available.
2.
Boskoski I, Lopez-Nava G, Ravishankar A, Bove V, Matteo M, De Siena M, et al.
Gastrointest Endosc
. 2024 Sep;
PMID: 39307402
Background And Aims: EndoZip (Nitinotes Ltd, Cesarea, Israel) is a fully automated, operator-independent robotic endoscopic suturing device developed for gastric volume reduction and treatment of obesity. We aim to assess...
3.
Ali H, Patel P, Malik T, Pamarthy R, Mohan B, Asokkumar R, et al.
Gastrointest Endosc
. 2023 Jun;
98(5):747-754.e5.
PMID: 37263362
Background And Aims: Reintervention after endoscopic sleeve gastroplasty (ESG) can be indicated because of postprocedural adverse events from various preinterventional or postprocedural comorbidities. We developed and internally validated an ESG...
4.
Negi A, Asokkumar R, Ravi R, Lopez-Nava G, Bautista-Castano I
Nutrients
. 2022 Aug;
14(16).
PMID: 36014956
The prevalence of obesity has risen exponentially, and patients living with obesity suffer from its debilitating consequences. The treatment options for obesity have expanded significantly and include lifestyle changes, pharmacotherapy,...
5.
Rapaka B, Maselli D, Lopez-Nava G, Bautista-Castano I, Matar R, Jaruvongvanich V, et al.
Chin Med J (Engl)
. 2022 Jul;
135(10):1234-1241.
PMID: 35788090
Background: Endoscopic bariatric therapies can help address widening management gaps in obesity. Their ability to facilitate weight loss is largely tied to influences on appetite through perturbations of gastric emptying...
6.
Normand E, Montero A, Lopez-Nava G, Bautista-Castano I
Nutrients
. 2022 Mar;
14(3).
PMID: 35276953
Obesity is an expanding disease responsible for significant deterioration in the Health-Related Quality of Life (HRQL) of those who suffer from it. Bariatric Endoscopy (BE) therapies have proven to be...
7.
Asokkumar R, Lim C, Tan A, Lee P, Eng A, Tan J, et al.
JGH Open
. 2021 Dec;
5(12):1351-1356.
PMID: 34950778
Background And Aim: Endoscopic sleeve gastroplasty (ESG) is an alternative nonsurgical treatment option for obesity. However, most studies on the utility and efficacy of ESG are derived from the Western...
8.
Maselli D, Abusaleh R, Trad K, Lopez-Nava G, Turro R, Abu Dayyeh B
Endoscopy
. 2021 May;
54(5):E203-E204.
PMID: 33979860
No abstract available.
9.
10.
Lopez-Nava G, Laster J, Negi A, Fook-Chong S, Bautista-Castano I, Asokkumar R
Surg Endosc
. 2021 Jan;
36(1):352-360.
PMID: 33492503
Introduction: ESG is an effective treatment for classes I and II obesity. However, the benefit of ESG in patients with morbid obesity (BMI ≥ 40 kg/m) who decline surgery is...